Ångström AI: Using AI to Simulate Molecular Physics Instead of Running Drug Experiments
A Cambridge/San Francisco startup uses its PDMD framework and ChemGNN neural network to simulate molecular physics, replacing wet-lab experiments in drug discovery, and has already partnered with AstraZeneca.
Think & Rich